[1]袁茜宁,董怡晨,卿玲玲,等.不同蛋白尿水平IgA肾病患者的临床及病理特征分析[J].医学信息,2024,37(08):104-108,113.[doi:10.3969/j.issn.1006-1959.2024.08.020]
　YUAN Qian-ning,DONG Yi-chen,QING Ling-ling,et al.Analysis of Clinical and Pathological Characteristics of IgA Nephropathy Patients with Different Proteinuria Levels[J].Journal of Medical Information,2024,37(08):104-108,113.[doi:10.3969/j.issn.1006-1959.2024.08.020]
点击复制

不同蛋白尿水平IgA肾病患者的临床及病理特征分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年08期
页码:
104-108,113
栏目:
论著
出版日期:
2024-04-15

文章信息/Info

Title:
Analysis of Clinical and Pathological Characteristics of IgA Nephropathy Patients with Different Proteinuria Levels
文章编号:
1006-1959（2024）08-0104-06
作者:
袁茜宁; 董怡晨; 卿玲玲; 等
（1.石河子大学医学院，新疆 石河子 832008；2.石河子大学医学院第一附属医院肾病科，新疆 石河子 832008）
Author(s):
YUAN Qian-ning; DONG Yi-chen; QING Ling-ling; et al.
(1.Shihezi University School of Medicine,Shihezi 832008,Xinjiang,China;2.Department of Nephrology,the First Affiliated Hospital of Shihezi University School of Medicine,Shihezi 832008,Xinjiang,China)
关键词:
IgA肾病; 病理特征; 24 h尿蛋白定量; WHO分型; 估算肾小球滤过率
Keywords:
IgA nephropathy; Clinical characteristics; 24-hour urinary protein quantification; WHO classification; Estimate glomerular filtration rate
分类号:
R692
DOI:
10.3969/j.issn.1006-1959.2024.08.020
文献标志码:
A
摘要:
目的 探讨不同蛋白尿水平的原发性IgA肾病患者临床及病理特征。方法 选取2010年1月-2021年12月石河子大学医学院第一附属医院经肾活检诊断为IgA肾病患者204例，根据24 h尿蛋白定量水平将患者分为4组：＜0.3 g/d（A组，48例）、0.3~0.99 g/d（B组，67例）、1~1.99 g/d（C组，43例）、≥2 g/d（D组，46例）。比较四组临床资料，并采用Spearman相关分析尿蛋白定量与临床指标的关系，采用Kaplan-Meier曲线分析肾脏累积生存率。结果 ①四组白蛋白（ALB）、总蛋白（TP）、肌酐（Scr）、尿素氮（BUN）、估算肾小球滤过率（eGFR）、总胆固醇（TC）、血清IgG、牛津分级、WHO分型比较，差异有统计学意义（P＜0.05）；②Spearman相关分析显示，随着ALB、TP、eGFR、IgG降低及Scr、BUN、TC升高，24 h尿蛋白定量水平增加；③Kaplan-Meier曲线分析显示，A组肾脏累积生存率较B组、C组、D组高，D组较B组、C组低。结论 IgA肾病病理分级与临床指标间存在密切联系，随着尿蛋白定量的增加，IgA肾病患者肾功能减退、病理改变损害程度加重、肾脏累积生存率下降。
Abstract:
Objective To investigate the clinical and pathological features of primary IgA nephropathy patients with different proteinuria levels.Methods A total of 204 patients with IgA nephropathy diagnosed by renal biopsy in the First Affiliated Hospital of Shihezi University School of Medicine from January 2010 to December 2021 were selected. According to the level of 24-hour urinary protein quantification, the patients were divided into 4 groups: <0.3 g/d (group A, 48 patients), 0.3-0.99 g/d (group B, 67 patients), 1-1.99 g/d (group C, 43 patients), ≥2 g/d (group D, 46 patients). The clinical data of the four groups were compared, and the relationship between urinary protein quantification and clinical indicators was analyzed by Spearman correlation. Kaplan-Meier curve was used to analyze the cumulative survival rate of kidney.Results ①There were significant differences in albumin (ALB), total protein (TP), creatinine (Scr), urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), total cholesterol (TC), serum IgG, Oxford classification and WHO classification among the four groups (P<0.05); ②Spearman correlation analysis showed that with the decrease of ALB, TP, eGFR, IgG and the increase of Scr, BUN and TC, the quantitative level of 24-hour urine protein increased; ③Kaplan-Meier curve analysis showed that the cumulative survival rate of kidney in group A was higher than that in group B, group C and group D, and the cumulative survival rate of kidney in group D was lower than that in group B and group C.Conclusion There is a close relationship between the pathological grade of IgA nephropathy and clinical indicators. With the increase of urinary protein quantification, the renal function of patients with IgA nephropathy decreases, the degree of pathological damage increases, and the cumulative survival rate of kidney decreases.

参考文献/References:

[1]Rodrigues JC,Haas M,Reich HN.IgA Nephropathy[J].Clin J Am Soc Nephrol,2017,12(4):677-686.[2]Feldmann Y,B?觟er K,Wolf G,et al.Complications and monitoring of percutaneous renal biopsy - a retrospective study[J].Clin Nephrol,2018,89(4):260-268.[3]Imai N,Shirai S,Yasuda T,et al.Long-term prognosis of IgA nephropathy presenting with minimal or no proteinuria: A single center experience[J].Indian J Nephrol,2016,26(2):107-112.[4]Le W,Liang S,Hu Y,et al.Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population[J].Nephrol Dial Transplant,2012,27(4):1479-1485.[5]魏兰,刘立桥,白静,等.MCP-1、TLR-4及尿蛋白定量与原发性IgA肾病病理损伤的相关性研究[J].解放军医药杂志,2019,31(1):40-44.[6]廖莹,许日聪,胡豪飞,等.大量蛋白尿IgA肾病血清白蛋白与新月体比例的关系[J].中国医师杂志,2018,20(10):1567-1569.[7]袁燕红,王琴,张敏芳,等.血清白蛋白对IgA肾病患者肾脏预后的预测价值[J].中华肾脏病杂志,2015,31(2):102-108.[8]Liu D,You J,Liu Y,et al.Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy[J].Int Immunopharmacol,2019,66:13-18.[9]Maixnerova D,Ling C,Hall S,et al.Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression[J].PLoS One,2019,14(2):e0212254.[10]符育群.血清IgG在IgAN患者中的表达及其对肾脏转归的预测作用[J].现代免疫学,2019,39(6):476-479.[11]王晓宇,张宏志.24 h尿蛋白定量与IgA肾病病理改变的相关性研究[J].医技与临床,2015,13(22):82-83.[12]Gutiérrez E,Moreno JA,Praga M,et al.Persistent microhaematuria with negative or low proteinuria[J].Nefrologia,2014,4(1):110-114.[13]吴玲燕,朱琼,王旭,等.IgA肾病患者尿蛋白定量水平与临床病理特征的相关性分析[J].湖南师范大学学报(医学版),2022,19(3):57-60.[14]Yau T,Korbet SM,Schwartz MM,et al.The Oxford classification of IgA nephropathy:a retrospective analysis[J].Am J Nephrol,2011,34(5):435-444.[15]Floege J,Wied S,Rauen T.Assessing prognosis in IgA nephropathy[J].Kidney Int,2022,102(1):22-24.[16]Liu BC,Tang TT,Lv LL,et al.Renal tubule injury:a driving force toward chronic kidney disease[J].Kidney Int,2018,93(3):568-579.[17]邱江,陈国栋,张锦.尿蛋白定量联合eGFR在评估移植肾IgA肾病病理损伤程度中的应用[J].中华器官移植杂志,2022,41(10):592-596.[18]Coppo R,Troyanov S,Bellur S,et al.Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments[J].Kidney Int,2014,86(4):828-836.[19]Nam KH,Kie JH,Lee MJ,et al.Optimal proteinuria target for renoprotection in patients with IgA nephropathy[J].PLoS One,2014,9(7):e101935.[20]Ai Z,Zhou Q,Huang F,et al.Long-term renal outcomes of IgA nephropathy presenting with different levels of proteinuria[J].Clin Nephrol,2020,94(6):290-296.

相似文献/References:

[1]张如意.动脉瘤样纤维组织细胞瘤4例临床病理观察[J].医学信息,2019,32(01):173.[doi:10.3969/j.issn.1006-1959.2019.01.055]
　ZHANG Ru-yi.Clinicopathological Observation of 4 Cases of Aneurysmal Fibroblastoma[J].Journal of Medical Information,2019,32(08):173.[doi:10.3969/j.issn.1006-1959.2019.01.055]
[2]陈 越,彭 莉.黄芪对细胞毒素相关蛋白A诱导的大鼠系膜细胞外基质分泌的影响[J].医学信息,2022,35(15):104.[doi:10.3969/j.issn.1006-1959.2022.15.023]
　CHEN Yue,PENG Li.Effect of Astragalus Membranaceus on CagA-induced Extracellular Matrix Secretion of Rat Mesangial Cells[J].Journal of Medical Information,2022,35(08):104.[doi:10.3969/j.issn.1006-1959.2022.15.023]
[3]刘 枫.IgA肾病与系膜增生性肾炎临床特征的比较[J].医学信息,2019,32(16):95.[doi:10.3969/j.issn.1006-1959.2019.16.029]
　LIU Feng.Comparison of Clinical Features between IgA Nephropathy and Mesangial Proliferative Nephritis[J].Journal of Medical Information,2019,32(08):95.[doi:10.3969/j.issn.1006-1959.2019.16.029]
[4]黄 婷,张亚莉,李 燕,等.不同性别IgA肾病患者相关临床指标及病理特点对比[J].医学信息,2019,32(21):125.[doi:10.3969/j.issn.1006-1959.2019.21.040]
　HUANG Ting,ZHANG Ya-li,LI Yan,et al.Comparative Analysis of Clinical and Pathological Features of Patients with Different Sex IgA Nephropathy[J].Journal of Medical Information,2019,32(08):125.[doi:10.3969/j.issn.1006-1959.2019.21.040]
[5]赵博志,赵国林,杨 敏,等.乳腺鳞状细胞癌的临床诊疗研究[J].医学信息,2020,33(03):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]
　ZHAO Bo-zhi,ZHAO Guo-lin,YANG Min,et al.Clinical Diagnosis and Treatment of Squamous Cell Carcinoma of the Breast[J].Journal of Medical Information,2020,33(08):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]
[6]高 协.胃癌中表皮生长因子受体2蛋白表达与临床病理特征的关系[J].医学信息,2020,33(13):57.[doi:10.3969/j.issn.1006-1959.2020.13.016]
　GAO Xie.Relationship Between Epidermal Growth Factor Receptor 2 Protein Expression and Clinicopath-ological Characteristics in Gastric Cancer[J].Journal of Medical Information,2020,33(08):57.[doi:10.3969/j.issn.1006-1959.2020.13.016]
[7]刘永芳,王 莹.付义主任治疗IgA肾病经验[J].医学信息,2020,33(21):155.[doi:10.3969/j.issn.1006-1959.2020.21.048]
[8]张文娟,郭永泽,程丽敏,等.miR-106b-3p和miR-214在食管鳞癌组织中的表达及其与临床病理特征的关系[J].医学信息,2021,34(03):116.[doi:10.3969/j.issn.1006-1959.2021.03.032]
　ZHANG Wen-juan,GUO Yong-ze,CHENG Li-min,et al.The Epression of miR-106b-3p and miR-214 in Esophageal Squamous Cell Carcinoma and Its Relationship with Clinicopathological Characteristics[J].Journal of Medical Information,2021,34(08):116.[doi:10.3969/j.issn.1006-1959.2021.03.032]
[9]郑桌龙,林 钢,罗勉那,等.成人IgA肾病免疫抑制治疗的研究进展[J].医学信息,2023,36(14):183.[doi:10.3969/j.issn.1006-1959.2023.14.040]
　ZHENG Zhuo-long,LIN Gang,LUO Mian-na,et al.Research Progress on Immunosuppressive Therapy for IgA Nephropathy in Adults[J].Journal of Medical Information,2023,36(08):183.[doi:10.3969/j.issn.1006-1959.2023.14.040]
[10]李东松,陈娉珊,蔡泰楠,等.错配修复蛋白表达缺失与结直肠癌病理特征及预后的关系[J].医学信息,2024,37(08):99.[doi:10.3969/j.issn.1006-1959.2024.08.019]
　LI Dong-song,CHEN Ping-shan,CAI Tai-nan,et al.Relationship Between the Loss of Mismatch Repair Protein Expression and the Pathological Feature and Prognosis of Colorectal Cancer[J].Journal of Medical Information,2024,37(08):99.[doi:10.3969/j.issn.1006-1959.2024.08.019]

更新日期/Last Update: 1900-01-01